# Erythropoietin Gel as an Adjunct to Xenograft in the Surgical Management of Intrabony Periodontal Defects

> **NCT05360511** · EARLY_PHASE1 · COMPLETED · sponsor: **Ain Shams University** · enrollment: 26 (actual)

## Conditions studied

- Periodontal Bone Loss

## Interventions

- **DRUG:** particulate xenograft + erythropoietin gel.
- **COMBINATION_PRODUCT:** particulate xenograft

## Key facts

- **NCT ID:** NCT05360511
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-01
- **Primary completion:** 2023-09-01
- **Final completion:** 2023-10-01
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2024-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05360511

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05360511, "Erythropoietin Gel as an Adjunct to Xenograft in the Surgical Management of Intrabony Periodontal Defects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05360511. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*